Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Pozycja w akcjach #30195
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Cena akcji
$0.22227521
Kapitalizacja rynkowa
$17.81M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-14.81%
Kraj
TW
Handel TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Kategoria

Historia ceny akcji dla TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Najwyższa cena zamknięcia: $0.22 dnia 2026-08-01

Najniższa cena zamknięcia: $1.48 dnia 2015-10-01
Historia cen akcji firmy TaiwanJ Pharmaceuticals Co., Ltd. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -0.02%
2025 -4.42%
2024 -46.55%
2023 39.35%
2022 -2.83%
2021 -22.13%
2020 32.12%
2019 63.58%
2018 -45.16%
2017 -41.89%
2016 -53.24%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$527.89 35.09%
US
$996.61 51.72%
NL
$116.20 -20.17%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE